Skip to content

H.R. 3789 · 119th Congress (2025–2027)

DTC Act of 2025

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025

This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.

Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.

The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Show official title

To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 3789’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. David J. Taylor (R-OH-2)
Cosponsors
8 cosponsors

1 original · 7 later

4 R · 4 D

  1. Rep. Janice D. Schakowsky (D-IL-9)· Original · Jun 5, 2025
  2. Rep. Nicholas J. Begich III (R-AK)· Later · Jul 2, 2025
  3. Rep. Mike Quigley (D-IL-5)· Later · Jul 2, 2025
  4. Rep. Robert P. Bresnahan, Jr. (R-PA-8)· Later · Sep 30, 2025
  5. Del. Eleanor Holmes Norton (D-DC)· Later · Sep 30, 2025
  6. Rep. Zachary Nunn (R-IA-3)· Later · Oct 3, 2025
  7. Rep. Eugene Simon Vindman (D-VA-7)· Later · Oct 21, 2025
  8. Rep. Ashley Hinson (R-IA-2)· Later · Jan 13, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jun 5, 2025
  2. HouseWays and MeansReferred Jun 5, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. DTC Act of 2025

    Display title, Short title · Introduced in House

  2. Drug-price Transparency for Consumers Act of 2025

    Short title · Introduced in House

  3. To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.

    Official title · Introduced in House